Eton is pricing tomrw if all goes well. The underwriter leaves a lot to be desired but it sure beats no IPO. Another item is the presentation of Melt in Chicago this weekend. Melt could be huge. https://globenewswire.com/news-release/2018/10/16/1621771/0/en/ImprimisRx-to-feature-new-formulation-and-poster-presentation-on-MKO-Melt-at-the-upcoming-American-Academy-of-Ophthalmology-Meeting-in-Chicago.html